The formation of a confluent endothelial layer on newly implanted vascular implants is essential for attenuation of inflammation and coagulation. Recent innovative methods have focused on the in-situ engineering of the interface between vascular grafts and the blood to capture circulating ECs with EC specific ligands or cell adhesion molecules, thereby accelerating endothelialization.